Target intelligence / Profile preview

Neural precursor cell differentiation

Molecular classification
Other
01

Overview

Neural precursor cell differentiation is the biological process by which multipotent neural stem and progenitor cells (NPCs) undergo a series of molecular and morphological changes to become specialized functional cells of the nervous system, such as neurons, astrocytes, or oligodendrocytes [2, 7]. This process is fundamental to the development of the mammalian central nervous system and continues throughout life in specific adult neurogenic niches like the subventricular zone and the hippocampal dentate gyrus [6, 10, 12]. The differentiation of NPCs is tightly regulated by a coordinated interplay between cell-intrinsic transcription factors, such as SOX2 and NeuroD1, and extrinsic signaling pathways including Notch, Wnt, Sonic Hedgehog (Shh), and Bone Morphogenetic Protein (BMP) [2, 10]. While "neural precursor cell differentiation" is a physiological process (GO:0048667) rather than a single molecular target, it is a primary focal point for therapeutic intervention in regenerative medicine and oncology [7, 8, 9]. Pharmacological modulation using agents such as retinoic acid, Notch inhibitors, or growth factors aims to promote tissue repair in neurodegenerative conditions or to induce terminal differentiation in cancer stem cells, which often exhibit blocked differentiation pathways in brain tumors [3, 6, 8, 10].

Other names
NeurogenesisNeuronal differentiationNPC differentiationNeural progenitor cell differentiationGO:0048667
02

Mechanism of action

Small molecules and biologics modulate this biological process by targeting signaling pathways such as Notch, Wnt, Shh, and BMP, as well as epigenetic regulators like HDACs, to either induce or inhibit the maturation of neural stem and progenitor cells into specific neural or glial lineages.

03

Biological functions

Cell differentiationNeurogenesisCentral nervous system developmentSignal transductionCell proliferation
04

Disease associations

Neurodegenerative diseaseCancerNeurodevelopmental disordersStrokeTraumatic brain injuryAlzheimer's diseaseParkinson's disease
05

Safety considerations

Risk of tumorigenicity (teratoma or glioblastoma formation)Ectopic or aberrant differentiationPotential for malformed or non-functional neural circuitsInflammatory response to exogenous cell or gene therapiesOff-target neurotoxicity
06

Interacting drugs

Retinoic acid

6 more in the full profile.

07

Biomarkers

NestinSOX2PAX6Beta-III Tubulin (TUJ1)MAP2NeuNGFAPOlig2

Beyond the preview

Go deeper on Neural precursor cell differentiation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neural precursor cell differentiation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call